Takeda Pharmaceutical’s Long-term Incentive System Introduction and Share Buyback｜June 2026

Overview of Capital Policy

Takeda Pharmaceutical will carry out the issuance of new shares and share buyback on July 8, 2026, as part of the long-term incentive system for overseas employees. A total of 16,989,076 shares will be allocated to beneficiaries, including the type of shares, with a total value of approximately 8.58 billion yen. This aims to incentivize employee retention and strategic advancement. The newly issued shares will be allocated to employees of the Company and its subsidiaries, and the share buyback will be conducted through the disposal of treasury stock. The issuance and disposal prices are determined based on the closing prices of the Tokyo Stock Exchange on the business day prior to the decision date.

Purpose and Future Outlook

This share buyback is part of a long-term incentive scheme aimed at employee retention and enhancement of corporate value. The beneficiaries include 10,557 employees of the Company and its subsidiaries, who will receive not only allocated shares but also cash reward claims. Aside from strengthening financial strategy through fundraising, the company plans to continue prioritizing employee motivation and maximizing corporate value.